TY  - GEN
AU  - Cascinu,Stefano
AU  - Labianca,Roberto
AU  - Barone,Carlo
AU  - Santoro,Armando
AU  - Carnaghi,Carlo
AU  - Cassano,Alessandra
AU  - Beretta,Giordano D
AU  - Catalano,Vincenzo
AU  - Bertetto,Oscar
AU  - Barni,Sandro
AU  - Frontini,Luciano
AU  - Aitini,Enrico
AU  - Rota,Silvia
AU  - Torri,Valter
AU  - Floriani,Irene
AU  - Pozzo,Carmelo
AU  - Rimassa,Lorenza
AU  - Mosconi,Stefania
AU  - Giordani,Paolo
AU  - Ardizzoia,Antonio
AU  - Foa,Paolo
AU  - Rabbi,Carla
AU  - Chiara,Silvana
AU  - Gasparini,Giampietro
AU  - Nardi,Mario
AU  - Mansutti,Mauro
AU  - Arnoldi,Ermenegildo
AU  - Piazza,Elena
AU  - Cortesi,Enrico
AU  - Pucci,Francesca
AU  - Silva,Rosa Rita
AU  - Sobrero,Alberto
AU  - Ravaioli,Alberto
TI  - Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial
SN  - 1460-2105
PY  - 2007///0430
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Chemotherapy, Adjuvant
KW  - Cisplatin
KW  - Disease-Free Survival
KW  - Drug Administration Schedule
KW  - Epirubicin
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Leucovorin
KW  - Lymphatic Metastasis
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Invasiveness
KW  - Stomach Neoplasms
KW  - drug therapy
KW  - Survival Analysis
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1093/jnci/djk131
ER  -